Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

Name: Medicxi Ventures Management (Jersey) Ltd Q4 2020 13F Filing | 13F Explorer
Creator: Medicxi Ventures Management (Jersey) Ltd
Published: 2021-02-12

Location: St. Helier, Jersey

CIK: 0001715579 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 12, 2021

Total Value: $172M (100.0% shares, 0.0% debt)

Holdings (5)

PHAT PHATHOM PHARMACEUTICALS INC 39.9%

Value $68.69M Shares 2,067,861 Share Price $33.22 Est. Cost/Share $25.13 Unrealized @ Report Date +32.2%

PCVX VAXCYTE INC 29.1%

Value $50.15M Shares 1,887,478 Share Price $26.57 Est. Cost/Share $32.16 Unrealized @ Report Date -17.4%

— MERUS N V 16.3%

Value $28.05M Shares 1,600,000 Share Price $17.53 Est. Cost/Share $14.08 Unrealized @ Report Date —

— CHECKMATE PHARMACEUTICALS IN 12.7%

Value $21.91M Shares 1,501,716 Share Price $14.59 Est. Cost/Share $11.51 Unrealized @ Report Date —

— OBSEVA SA 1.9%

Value $3.266M Shares 1,570,000 Share Price $2.08 Est. Cost/Share $3.82 Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
PHAT	PHATHOM PHARMACEUTICALS INC	2,067,861	$68.69M	39.9%	$33.22	$25.13	+32.2%	COM	71722W107
PCVX	VAXCYTE INC	1,887,478	$50.15M	29.1%	$26.57	$32.16	-17.4%	COM	92243G108
—	MERUS N V	1,600,000	$28.05M	16.3%	$17.53	$14.08	—	COM	N5749R100
—	CHECKMATE PHARMACEUTICALS IN	1,501,716	$21.91M	12.7%	$14.59	$11.51	—	COM	162818108
—	OBSEVA SA	1,570,000	$3.266M	1.9%	$2.08	$3.82	—	COM	H5861P103